ATNM
Actinium Pharmaceuticals Inc
1.20$
+2.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -3,475.4% | -1,824.0% | 839.2% | -58,438.3% | – | -27,311.1% | |
| – | – | – | – | – | – | 71.9% | 45.8% | 67.9% | 975.3% | – | 912.2% | |
| – | – | – | – | – | – | 201.6% | 148.1% | 271.4% | 4,743.2% | – | 10,211.1% | |
| – | – | – | – | – | – | 201.6% | 148.1% | 271.4% | – | – | – | |
| – | – | – | – | – | – | -177.3% | 147.7% | 3,705.5% | -3,887.7% | – | -782.2% | |
| – | – | – | – | – | – | 40.7% | 11.6% | 35.5% | 188.9% | – | 115.6% | |
| – | – | – | – | – | – | -40.7% | -11.6% | -35.5% | -188.9% | – | -115.6% | |
| – | – | – | – | – | – | 0.2% | – | – | – | – | – | |
| – | – | – | – | – | – | 0.2% | 3,086.2% | – | – | – | -230.0% | |
| – | – | – | – | – | – | -74.0% | -7.4% | -4.8% | -4.9% | – | -11.1% | |
| – | – | – | – | – | – | 12,246.9% | 3,078.8% | 2,243.6% | 18,358.0% | – | -241.1% | |
| – | – | – | – | – | – | 8,730.9% | 1,243.2% | 3,047.3% | -40,282.7% | – | -27,661.1% | |
| – | – | – | – | – | – | -3,516.1% | -1,835.6% | 803.7% | -58,627.2% | – | -27,426.7% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.